Tissue hOGG1 Genotype Predicts Bladder Cancer Prognosis: A Novel Approach Using a Peptide Nucleic Acid Clamping Method

[1]  J. Witjes,et al.  Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. , 2011, European urology.

[2]  R. D. Mittal,et al.  Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population? , 2009, Mutation research.

[3]  Wun-Jae Kim,et al.  Environmental factors promoting bladder cancer , 2009, Current opinion in urology.

[4]  Gerhard Jakse,et al.  The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. , 2009, European urology.

[5]  M. Gaub,et al.  Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping , 2009, British Journal of Cancer.

[6]  M. Babjuk,et al.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. , 2008, European urology.

[7]  K. Hemminki,et al.  Polymorphisms in XPD, XPC and the risk of death in patients with urinary bladder neoplasms , 2007, Acta oncologica.

[8]  Xifeng Wu,et al.  High-Order Interactions among Genetic Variants in DNA Base Excision Repair Pathway Genes and Smoking in Bladder Cancer Susceptibility , 2007, Cancer Epidemiology Biomarkers & Prevention.

[9]  Huqun,et al.  Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp. , 2005, Cancer research.

[10]  S. Shiesh,et al.  Rapid detection of K-ras mutations in bile by peptide nucleic acid-mediated PCR clamping and melting curve analysis: comparison with restriction fragment length polymorphism analysis. , 2004, Clinical chemistry.

[11]  F. Greene.  The American Joint Committee on Cancer: updating the strategies in cancer staging. , 2002, Bulletin of the American College of Surgeons.

[12]  E. Friedberg.  How nucleotide excision repair protects against cancer , 2001, Nature Reviews Cancer.

[13]  W. Tan,et al.  Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population , 2001, International journal of cancer.

[14]  H. Dienemann,et al.  hOGG1 polymorphism and loss of heterozygosity (LOH): Significance for lung cancer susceptibility in a caucasian population , 2000, International journal of cancer.

[15]  P Vineis,et al.  Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. , 2000, Journal of the National Cancer Institute.

[16]  B. Morris,et al.  hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  W C Willett,et al.  The causes and prevention of cancer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Egholm,et al.  Single base pair mutation analysis by PNA directed PCR clamping. , 1993, Nucleic acids research.

[19]  J. Miller,et al.  Evidence that MutY and MutM combine to prevent mutations by an oxidatively damaged form of guanine in DNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Babjuk,et al.  Reply to Anna Orsola, Lluís Cecchini and Juan Morote's Letter to the Editor re: Marko Babjuk, Willem Oosterlinck, Richard Sylvester, et al. EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder. Eur Urol 2008;54:303–14 , 2009 .

[21]  Wun-Jae Kim,et al.  Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. , 2005, Urology.